L-type amino acid transporter 1 (LAT1)-utilizing efflux transporter inhibitors can improve the brain uptake and apoptosis-inducing effects of vinblastine in cancer cells
- 1 August 2020
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 586, 119585
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland
- Uniwersytet Medyczny w Lodzi
This publication has 43 references indexed in Scilit:
- Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cellsBMC Veterinary Research, 2013
- Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1Oncology Letters, 2011
- Pegylated Phosphotidylethanolamine Inhibiting P-Glycoprotein Expression and Enhancing Retention of Doxorubicin in MCF7/ADR CellsJournal of Pharmaceutical Sciences, 2011
- Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptorsJournal of Neurochemistry, 2011
- Biocompatibility and characteristics of injectable chitosan-based thermosensitive hydrogel for drug deliveryCarbohydrate Polymers, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology, 2009
- On the mechanisms of biocompatibilityBiomaterials, 2008
- High expression of L-type amino acid transporter 1 in infiltrating glioma cellsBrain Tumor Pathology, 2005
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981